Brief: Caplin Point Laboratories Unit Signs Pact With Xellia Pharmaceuticals
07/07/2020 05:40
July 7 (Reuters) - Caplin Point Laboratories Ltd CAPL.NS :
* CAPLIN STERILES SIGNS PACT WITH XELLIA PHARMACEUTICALS
* CAPLIN STERILES TO LICENSE 5 INJECTABLE ANDAS TO XELLIA
* APPROVAL FOR 4 PRODUCTS EXPECTED WITHIN NEXT 12-18 MONTHS
Source text for Eikon: ID:nBSE4rrMJC
Further company coverage: CAPL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Caplin Point Laboratories
See all newsBrief: Caplin Point Laboratories Says US FDA Completes Unannounced Inspection Of Caplin Steriles Gummidipoondi Facility
Brief: Caplin Point Laboratories March-Quarter Consol Net Profit 1.7 Bln Rupees
Brief: Caplin Point Laboratories Unit Receives Final USFDA Approval For ANDA Potassium Phosphates Injection
Brief: Caplin Point Laboratories Says Unit Receives USFDA Approval For Sodium Phosphates Injection
Brief: Caplin Point Laboratories Dec-Quarter Consol Net Profit 1.64 Billion Rupees